605 related articles for article (PubMed ID: 33271067)
1. Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains.
Zhou T; Tsybovsky Y; Gorman J; Rapp M; Cerutti G; Chuang GY; Katsamba PS; Sampson JM; Schön A; Bimela J; Boyington JC; Nazzari A; Olia AS; Shi W; Sastry M; Stephens T; Stuckey J; Teng IT; Wang P; Wang S; Zhang B; Friesner RA; Ho DD; Mascola JR; Shapiro L; Kwong PD
Cell Host Microbe; 2020 Dec; 28(6):867-879.e5. PubMed ID: 33271067
[TBL] [Abstract][Full Text] [Related]
2. Cryo-EM Structures Delineate a pH-Dependent Switch that Mediates Endosomal Positioning of SARS-CoV-2 Spike Receptor-Binding Domains.
Zhou T; Tsybovsky Y; Olia AS; Gorman J; Rapp MA; Cerutti G; Chuang GY; Katsamba PS; Nazzari A; Sampson JM; Schon A; Wang PD; Bimela J; Shi W; Teng IT; Zhang B; Boyington JC; Sastry M; Stephens T; Stuckey J; Wang S; Friesner RA; Ho DD; Mascola JR; Shapiro L; Kwong PD
bioRxiv; 2020 Jul; ():. PubMed ID: 32637958
[TBL] [Abstract][Full Text] [Related]
3. Structural basis and analysis of hamster ACE2 binding to different SARS-CoV-2 spike RBDs.
Niu S; Zhao Z; Liu Z; Rong X; Chai Y; Bai B; Han P; Shang G; Ren J; Wang Y; Zhao X; Liu K; Tian W-x; Wang Q; Gao GF
J Virol; 2024 Mar; 98(3):e0115723. PubMed ID: 38305152
[TBL] [Abstract][Full Text] [Related]
4. Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.
Huo J; Le Bas A; Ruza RR; Duyvesteyn HME; Mikolajek H; Malinauskas T; Tan TK; Rijal P; Dumoux M; Ward PN; Ren J; Zhou D; Harrison PJ; Weckener M; Clare DK; Vogirala VK; Radecke J; Moynié L; Zhao Y; Gilbert-Jaramillo J; Knight ML; Tree JA; Buttigieg KR; Coombes N; Elmore MJ; Carroll MW; Carrique L; Shah PNM; James W; Townsend AR; Stuart DI; Owens RJ; Naismith JH
Nat Struct Mol Biol; 2020 Sep; 27(9):846-854. PubMed ID: 32661423
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies.
Barnes CO; Jette CA; Abernathy ME; Dam KA; Esswein SR; Gristick HB; Malyutin AG; Sharaf NG; Huey-Tubman KE; Lee YE; Robbiani DF; Nussenzweig MC; West AP; Bjorkman PJ
Nature; 2020 Dec; 588(7839):682-687. PubMed ID: 33045718
[TBL] [Abstract][Full Text] [Related]
6. The structural basis of accelerated host cell entry by SARS-CoV-2†.
Seyran M; Takayama K; Uversky VN; Lundstrom K; Palù G; Sherchan SP; Attrish D; Rezaei N; Aljabali AAA; Ghosh S; Pizzol D; Chauhan G; Adadi P; Mohamed Abd El-Aziz T; Soares AG; Kandimalla R; Tambuwala M; Hassan SS; Azad GK; Pal Choudhury P; Baetas-da-Cruz W; Serrano-Aroca Á; Brufsky AM; Uhal BD
FEBS J; 2021 Sep; 288(17):5010-5020. PubMed ID: 33264497
[TBL] [Abstract][Full Text] [Related]
7. Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function.
Yang TJ; Yu PY; Chang YC; Liang KH; Tso HC; Ho MR; Chen WY; Lin HT; Wu HC; Hsu SD
Nat Struct Mol Biol; 2021 Sep; 28(9):731-739. PubMed ID: 34385690
[TBL] [Abstract][Full Text] [Related]
8. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
[TBL] [Abstract][Full Text] [Related]
9. Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution.
Zhang S; Qiao S; Yu J; Zeng J; Shan S; Tian L; Lan J; Zhang L; Wang X
Nat Commun; 2021 Mar; 12(1):1607. PubMed ID: 33707453
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2.
Yan R; Zhang Y; Li Y; Xia L; Guo Y; Zhou Q
Science; 2020 Mar; 367(6485):1444-1448. PubMed ID: 32132184
[TBL] [Abstract][Full Text] [Related]
11. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
Huang SW; Miller SO; Yen CH; Wang SF
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
[TBL] [Abstract][Full Text] [Related]
12. Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain.
Ye G; Liu B; Li F
Nat Commun; 2022 Mar; 13(1):1214. PubMed ID: 35241675
[TBL] [Abstract][Full Text] [Related]
13. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
[TBL] [Abstract][Full Text] [Related]
14. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
Qiao B; Olvera de la Cruz M
ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion.
Xue S; Han Y; Wu F; Wang Q
Protein Cell; 2024 May; 15(6):403-418. PubMed ID: 38442025
[TBL] [Abstract][Full Text] [Related]
17. Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants.
Su C; He J; Han P; Bai B; Li D; Cao J; Tian M; Hu Y; Zheng A; Niu S; Chen Q; Rong X; Zhang Y; Li W; Qi J; Zhao X; Yang M; Wang Q; Gao GF
J Virol; 2022 Sep; 96(17):e0081422. PubMed ID: 36000849
[TBL] [Abstract][Full Text] [Related]
18. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
Elife; 2021 Aug; 10():. PubMed ID: 34435953
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2.
Yang R; Han P; Han P; Li D; Zhao R; Niu S; Liu K; Li S; Tian W-X; Gao GF
J Virol; 2024 May; 98(5):e0045124. PubMed ID: 38591877
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies.
Cerutti G; Rapp M; Guo Y; Bahna F; Bimela J; Reddem ER; Yu J; Wang P; Liu L; Huang Y; Ho DD; Kwong PD; Sheng Z; Shapiro L
Structure; 2021 Jul; 29(7):655-663.e4. PubMed ID: 34111408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
